Cardiovascular and adenylate cyclase stimulating effects of colforsin
daropate, a water-soluble forskolin derivative, compared with those of
isoproterenol, dopamine and dobutamine.
Yoneyama M, Sugiyama A, Satoh Y, Takahara A, Nakamura Y, Hashimoto K.
Department of Pharmacology, Yamanashi Medical University, Tamaho-cho, Nakakoma-gun,
Japan.
Colforsin daropate is a recently developed water-soluble derivative of forskolin
that directly stimulates adenylate cyclase, unlike the catecholamines. The
chronotropic, inotropic and coronary vasodilator actions of colforsin daropate
were compared with those of isoproterenol, dopamine and dobutamine, using canine
isolated, blood-perfused heart preparations. The stimulating effect of each drug
on adenylate cyclase activity was also assessed. Colforsin daropate, as well as
each of the catecholamines, exerted positive chronotropic, inotropic and
coronary vasodilator actions. The order of selectivity for the cardiovascular
variables of colforsin daropate was coronary vasodilation >> positive inotropy >
positive chronotropy; whereas that of isoproterenol, dopamine and dobutamine was
positive inotropy >> coronary vasodilation > positive chronotropy. Thus, a
marked characteristic of colforsin daropate is its potent coronary vasodilator
action. On the other hand, each drug significantly increased the adenylate
cyclase activity in a dose-related manner: colforsin daropate >> isoproterenol >
dopamine = dobutamine. These results suggest that colforsin daropate may be
preferable in the treatment of severe heart failure where the coronary blood
flow is reduced and beta-adrenoceptor-dependent signal transduction pathway is
down-regulated.